Cargando…

An anticancer drug suppresses the primary nucleation reaction that initiates the production of the toxic Aβ42 aggregates linked with Alzheimer’s disease

The conversion of the β-amyloid (Aβ) peptide into pathogenic aggregates is linked to the onset and progression of Alzheimer’s disease. Although this observation has prompted an extensive search for therapeutic agents to modulate the concentration of Aβ or inhibit its aggregation, all clinical trials...

Descripción completa

Detalles Bibliográficos
Autores principales:	Habchi, Johnny, Arosio, Paolo, Perni, Michele, Costa, Ana Rita, Yagi-Utsumi, Maho, Joshi, Priyanka, Chia, Sean, Cohen, Samuel I. A., Müller, Martin B. D., Linse, Sara, Nollen, Ellen A. A., Dobson, Christopher M., Knowles, Tuomas P. J., Vendruscolo, Michele
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Association for the Advancement of Science 2016
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4758743/ https://www.ncbi.nlm.nih.gov/pubmed/26933687 http://dx.doi.org/10.1126/sciadv.1501244

Ejemplares similares

Selective targeting of primary and secondary nucleation pathways in Aβ42 aggregation using a rational antibody scanning method
por: Aprile, Francesco A., et al.
Publicado: (2017)

Proliferation of Tau 304–380 Fragment Aggregates through Autocatalytic Secondary Nucleation
por: Rodriguez Camargo, Diana C., et al.
Publicado: (2021)

Infrared nanospectroscopy reveals the molecular interaction fingerprint of an aggregation inhibitor with single Aβ42 oligomers
por: Ruggeri, Francesco Simone, et al.
Publicado: (2021)

Surface-Catalyzed Secondary Nucleation Dominates the Generation of Toxic IAPP Aggregates
por: Rodriguez Camargo, Diana C., et al.
Publicado: (2021)

Secondary nucleation and elongation occur at different sites on Alzheimer’s amyloid-β aggregates
por: Scheidt, Tom, et al.
Publicado: (2019)

Transthyretin Inhibits Primary and Secondary Nucleations of Amyloid-β Peptide Aggregation and Reduces the Toxicity of Its Oligomers
por: Ghadami, Seyyed Abolghasem, et al.
Publicado: (2020)

Combinations of Vitamin A and Vitamin E Metabolites Confer Resilience against Amyloid-β Aggregation
por: Joshi, Priyanka, et al.
Publicado: (2023)

Screening of small molecules using the inhibition of oligomer formation in α-synuclein aggregation as a selection parameter
por: Staats, Roxine, et al.
Publicado: (2020)

Trodusquemine enhances Aβ(42) aggregation but suppresses its toxicity by displacing oligomers from cell membranes
por: Limbocker, Ryan, et al.
Publicado: (2019)

A dopamine metabolite stabilizes neurotoxic amyloid-β oligomers
por: Cataldi, Rodrigo, et al.
Publicado: (2021)

Publisher Correction: A dopamine metabolite stabilizes neurotoxic amyloid-β oligomers
por: Cataldi, Rodrigo, et al.
Publicado: (2021)

Nucleated Polymerisation in the Presence of Pre-Formed Seed Filaments
por: Cohen, Samuel I. A., et al.
Publicado: (2011)

SAR by kinetics for drug discovery in protein misfolding diseases
por: Chia, Sean, et al.
Publicado: (2018)

Two human metabolites rescue a C. elegans model of Alzheimer’s disease via a cytosolic unfolded protein response
por: Joshi, Priyanka, et al.
Publicado: (2021)

Publisher Correction: Two human metabolites rescue a C. elegans model of Alzheimer’s disease via a cytosolic unfolded protein response
por: Joshi, Priyanka, et al.
Publicado: (2021)

Biophysical approaches for the study of interactions between molecular chaperones and protein aggregates
por: Wright, Maya A., et al.
Publicado: (2015)

A Kinetic Map of the Influence of Biomimetic Lipid Model Membranes on Aβ(42) Aggregation
por: Baumann, Kevin N., et al.
Publicado: (2022)

Bacterial production and direct functional screening of expanded molecular libraries for discovering inhibitors of protein aggregation
por: Delivoria, Dafni C., et al.
Publicado: (2019)

Structure-Based Discovery of Small-Molecule Inhibitors of the Autocatalytic Proliferation of α-Synuclein Aggregates
por: Chia, Sean, et al.
Publicado: (2022)

Kinetic analysis reveals that independent nucleation events determine the progression of polyglutamine aggregation in C. elegans
por: Sinnige, Tessa, et al.
Publicado: (2021)

Interaction of the Molecular Chaperone DNAJB6 with Growing Amyloid-beta 42 (Aβ42) Aggregates Leads to Sub-stoichiometric Inhibition of Amyloid Formation
por: Månsson, Cecilia, et al.
Publicado: (2014)

A rationally designed bicyclic peptide remodels Aβ42 aggregation in vitro and reduces its toxicity in a worm model of Alzheimer’s disease
por: Ikenoue, Tatsuya, et al.
Publicado: (2020)

Modulation of electrostatic interactions to reveal a reaction network unifying the aggregation behaviour of the Aβ42 peptide and its variants
por: Meisl, Georg, et al.
Publicado: (2017)

Influence of denaturants on amyloid β42 aggregation kinetics
por: Weiffert, Tanja, et al.
Publicado: (2022)

On the role of sidechain size and charge in the aggregation of Aβ42 with familial mutations
por: Yang, Xiaoting, et al.
Publicado: (2018)

Spontaneous nucleation and fast aggregate-dependent proliferation of α-synuclein aggregates within liquid condensates at neutral pH
por: Dada, Samuel T., et al.
Publicado: (2023)

α-Synuclein Aggregation Is Triggered by Oligomeric Amyloid-β 42 via Heterogeneous Primary Nucleation
por: Vadukul, Devkee M., et al.
Publicado: (2023)

Amyloids and protein aggregation
por: Linse, Sara, et al.
Publicado: (2023)

Distinct thermodynamic signature of oligomer generation in the aggregation of the amyloid-β peptide
por: Cohen, Samuel I. A., et al.
Publicado: (2018)

Inversion of the Balance between Hydrophobic and Hydrogen Bonding Interactions in Protein Folding and Aggregation
por: Fitzpatrick, Anthony W., et al.
Publicado: (2011)

Microfluidic deposition for resolving single-molecule protein architecture and heterogeneity
por: Ruggeri, Francesco Simone, et al.
Publicado: (2018)

Kinetic analysis reveals the diversity of microscopic mechanisms through which molecular chaperones suppress amyloid formation
por: Arosio, Paolo, et al.
Publicado: (2016)

The Aβ40 and Aβ42 peptides self-assemble into separate homomolecular fibrils in binary mixtures but cross-react during primary nucleation
por: Cukalevski, Risto, et al.
Publicado: (2015)

Atomic force microscopy for single molecule characterisation of protein aggregation
por: Ruggeri, Francesco Simone, et al.
Publicado: (2019)

Different soluble aggregates of Aβ42 can give rise to cellular toxicity through different mechanisms
por: De, Suman, et al.
Publicado: (2019)

Optimization of a small molecule inhibitor of secondary nucleation in α-synuclein aggregation
por: Staats, Roxine, et al.
Publicado: (2023)

Adsorption free energy predicts amyloid protein nucleation rates
por: Toprakcioglu, Zenon, et al.
Publicado: (2022)

Enhancement of the Anti-Aggregation Activity of a Molecular Chaperone Using a Rationally Designed Post-Translational Modification
por: Lindstedt, Philip R., et al.
Publicado: (2019)

Rational design of a conformation-specific antibody for the quantification of Aβ oligomers
por: Aprile, Francesco A., et al.
Publicado: (2020)

Conformational Variability of Amyloid-β and the Morphological Diversity of Its Aggregates †
por: Yagi-Utsumi, Maho, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_uik3fdhrcjaicm95hlntjssjcq